Skip to content

Influence of BNP and other clinical indicators baseline and their change trajectory on cardiovascular prognosis in hemodialysis patients

Influence of BNP and other clinical indicators baseline and their change trajectory on cardiovascular prognosis in hemodialysis patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050998
Enrollment
Unknown
Registered
2021-09-10
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease in uremia

Interventions

case series:None

Sponsors

Tianjin Metabolic Diseases Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: In the past 3 years, chronic renal failure caused by various etiologies has received hemodialysis treatment, and the frequency of dialysis is three times a week. Dialysis access: AVF/AVG/long-term tube.

Exclusion criteria

Exclusion criteria: 1. Combined with malignant tumor, drug abuse, chronic atrial fibrillation and other chronic arrhythmias; 2. Body mass index >=40Kg/m^2; 3. Cannot study or conduct home blood pressure monitoring; 4. Expected survival period < 6 months; 5. Patients with known human immunodeficiency virus positive and other infectious diseases.

Design outcomes

Primary

MeasureTime frame
Brain natriuretic peptide;Myocardial enzyme;Troponin;Hemoglobin;Serum phosphorus;Serum calcium;Parathyroid hormone;Alkaline phosphatase;C-reactive protein;Serum ferrin;Blood glucose;Hemoglobinated;Electrocardiogram;Ultrosonic cardiogram;Cardiothoracic ratio;Cardiac magnetic resonance;Total cholesterol;Glycerides;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;Hosphospitalized for heart failure;Death of cardiovascular disease;Nonfatal stroke;Nonfatal myocardial infarction;

Secondary

MeasureTime frame
Bone mineral density;New-onset type of atrial fibrillation;Gastrointestinal bleeding;Infection;Malignancies;All-cause mortality;

Countries

China

Contacts

Public ContactYu Pei

Tianjin Metabolic Diseases Hospital

peiyu@tmu.edu.cn+86 13821008270

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026